Kerry

U.S.A

Fi Europe 2024

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Dosage Form : Tablet

Grade :

Brand Name : Disintequik™ ODT

Application : Co-Processed Excipients

Excipient Details : Orally Disintegrating Tablets

Pharmacopoeia Ref : USP/NF

Technical Specs :

Ingredient(s) : Crospovidone, Dextrose, Lactose, Mannitol

Dosage Form : Tablet

Grade :

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Ingredient(s) : Crospovidone, Dextrose, Lactose, Mannitol

Dosage Form : Tablet

Category : Co-Processed Excipients

Brand : DISINTEQUIK™ ODT

Applications : Orally Disintegrating Tablets

Pharmacopoeia Ref : USP/NF

Technical Specs : Not Available

Grade : Not Available

Looking for Pharmaceutical Excipients offered by Kerry? Find Octreotide Acetate to address your drug delivery challenges on PharmaCompass.

Octreotide Acetate

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

44 API Suppliers

27 USDMF

6 CEP/COS

4 JDMF

5 EU WC

1 KDMF

20 NDC API

25 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

23 Drugs in Development

FINISHED DOSAGE FORMULATIONS

238 FDF Dossiers

61 FDA Orange Book

92 Europe

11 Canada

48 Australia

8 South Africa

18 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

INJECTABLE;INJECTION - EQ 0.05MG BASE/ML

INJECTABLE;INJECTION - EQ 0.1MG BASE/ML

INJECTABLE;INJECTION - EQ 0.2MG BASE/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

INJECTABLE;INJECTION - EQ 0.5MG BASE/ML

INJECTABLE;INJECTION - EQ 1MG BASE/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

SOLUTION;SUBCUTANEOUS - 7MG/2.8ML (2.5MG/ML)

RELATED EXCIPIENT COMPANIES

1 Rochem International Inc

13 SPI Pharma

1 Faran Shimi Pharmaceutical

1 Pfanstiehl

2 Actylis

1 BASF

1 Finar

2 Gangwal Chemicals

1 Ingredion Pharma Solutions

2 Kerry

2 Microlex e.U

1 Pluviaendo

3 Roquette

1 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

1 Shijiazhuang Huaxu Pharmaceutical

1 Sigachi Industries

EXCIPIENTS BY APPLICATIONS

17 Fillers, Diluents & Binders

10 Chewable & Orodispersible Aids

9 Direct Compression

9 Taste Masking

7 Parenteral

4 Co-Processed Excipients

3 Disintegrants & Superdisintegrants

3 Granulation

2 API Stability Enhancers

1 Thickeners and Stabilizers

1 Topical

DIGITAL CONTENT

2 DATA COMPILATION #PharmaFlow

38 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

3 US Medicaid Prescriptions

79 Finished Drug Prices

10 Annual Reports

MARKET PLACE

15 APIs

16 FDF Dossiers

PATENTS & EXCLUSIVITIES

15 US Patents

1 US Exclusivities

REF. STANDARDS & IMPURITIES

2 USP

6 Others

Filters

Octreotide Acetate

INJECTABLE;INJECTION - EQ 0.2MG BASE/ML Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

INJECTABLE;INJECTION - EQ 1MG BASE/ML Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons